Active

STEANN PHARMA

Switched

BE0660893761

Rechtspersoon Private limited company 1 establishment

Hoogstraat 294, 2570 Duffel Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

10 year

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.
  • Figures corrected afterwards (2025).

Gross margin

€ 178,213

▼ 13% vs 2024

Profit

Growing

€ 228,374

▲ 91% vs 2024

Debts

Low

€ 1.1 million

▲ 50% vs 2024

STEANN PHARMA from Duffel, company number BE0660893761, closed financial year 2025 with a result of € 228,374 after tax. For that financial year STEANN PHARMA recorded a gross margin of € 178,213 and equity of € 958,845. Compared with financial year 2024, the result moved from € 119,291 to € 228,374. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 25, 2025.

What happened at STEANN PHARMA?

What happened at STEANN PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
  • New establishment in Duffel. KBO
  • Start of the company according to the CBE. KBO

In short

From € 108,508 profit in 2022 to € 228,374 profit in 2025.

Paid € 208,107 in corporate taxes since 2022.

Best year ever: 2025, with € 228,374 profit.

Paid out € 170,000 in dividends to the owners in total.

A new publication or filing at STEANN PHARMA? We notify you, reason included.

Follow STEANN PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Anneleen De Swert
STEANN PHARMA

Behind STEANN PHARMA is Anneleen De Swert. It owns 100% of ANW Soft and 100% of Apotheek Lisp itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Anneleen De Swert

Director

Also active at: A.N.W. - SOFT, Apotheek Lisp

Establishments

Establishment units

Physical locations of this company

Registered office

Hoogstraat 294 box C

2570 Duffel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0660.893.761
VAT number
BE 0660.893.761
Registered office
Hoogstraat 294 bus C, 2570 Duffel
Names & denominations
STEANN PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
12 August 2016
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What is the enterprise number of STEANN PHARMA?
The enterprise number of STEANN PHARMA is BE0660893761.
What is the address of STEANN PHARMA?
The registered office of STEANN PHARMA is located at Hoogstraat 294 box C, 2570 Duffel.
When was STEANN PHARMA founded?
STEANN PHARMA was founded on 12 August 2016.
What is the main activity of STEANN PHARMA?
The main activity of STEANN PHARMA is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does STEANN PHARMA have a website?
No website is currently known for STEANN PHARMA.
How much profit did STEANN PHARMA make in 2025?
STEANN PHARMA posted a profit after taxes of € 228,374 in financial year 2025.
What is the revenue of STEANN PHARMA?
As a small company, STEANN PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 178,213.
Where can I find the annual accounts of STEANN PHARMA?
STEANN PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of STEANN PHARMA?
According to the 2025 annual accounts, the directors of STEANN PHARMA are: Anneleen De Swert.
Who owns STEANN PHARMA?
Behind STEANN PHARMA is Anneleen De Swert. It owns 100% of ANW Soft and 100% of Apotheek Lisp itself.